What kind of company is Aczone?

What is Aczone?

Aczone (dapsone) gel 5% and 7.5% is a prescription topical acne medication used to treat inflammatory acne in patients aged 12 years and older.

Who makes Aczone?

Aczone is manufactured by Allergan, Inc., which was acquired by AbbVie Inc. in 2020. The drug was originally developed by QLT Inc., which was acquired by Auxilium Pharmaceuticals, Inc. in 2014.

History of Aczone

Aczone was first approved by the US Food and Drug Administration (FDA) in 2005 for the treatment of acne vulgaris. The approval was based on the results of five clinical trials involving more than 4,000 patients.

In 2008, Allergan acquired the rights to Aczone from QLT Inc. for $150 million. In 2020, AbbVie completed its acquisition of Allergan, including the rights to Aczone.

How does Aczone work?

Aczone contains an active ingredient called dapsone, which is a sulfone antibiotic that has anti-inflammatory properties. It works by reducing the inflammation associated with acne. Aczone also has antibacterial properties that help to kill the bacteria that can worsen acne.

What are the side effects of Aczone?

The most common side effects of Aczone include dryness, redness, itching, and oiliness of the skin. Less common side effects include anemia, headache, and nausea. Some people may also develop an allergic reaction to Aczone.

Availability of Aczone

Aczone is only available by prescription in the United States. It is available in two strengths: 5% and 7.5% gel. The drug is also available in Canada, the United Kingdom, and some other countries.

Conclusion

Aczone is a prescription topical acne medication that is used to treat inflammatory acne. It is manufactured by Allergan, Inc., and is available in two strengths: 5% and 7.5% gel. The drug contains dapsone, which has both anti-inflammatory and antibacterial properties. While Aczone can be an effective treatment for acne, it can also cause some side effects, and it is important to talk to a healthcare provider before using the drug.